Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones

The Journal of Infectious Diseases
P F McDermottDavid D Wagner

Abstract

Fluoroquinolones are commonly used to treat gastroenteritis caused by Campylobacter species. Domestically acquired fluoroquinolone-resistant Campylobacter infection has been documented recently in the United States. It has been proposed that the increase in resistance is due, in part, to the use of fluoroquinolones in poultry. In separate experiments, the effects of sarafloxacin and enrofloxacin treatment of Campylobacter jejuni-infected chickens on the development of ciprofloxacin resistance were measured. Fecal samples were collected before and after treatment and were cultured for C. jejuni. When enrofloxacin or sarafloxacin was used at US Food and Drug Administration-approved doses in broiler chickens, resistance developed rapidly and persisted in C. jejuni. MICs of ciprofloxacin increased from a base of 0.25 microg/mL to 32 microg/mL within the 5-day treatment time frame. These results show that the use of these drugs in chickens rapidly selects for resistant Campylobacter organisms and may result in less effective fluoroquinolone therapy for cases of human campylobacteriosis acquired from exposure to contaminated chicken.

Citations

May 19, 2004·Archives of Toxicology·Jung Hae YoonJaroslava Halper
Dec 29, 2004·Médecine et maladies infectieuses·Linda Tollefson, Beth E Karp
Aug 7, 2007·Epidemiology and Infection·J Y M JohnsonL D Saunders
Nov 9, 2002·Journal of Veterinary Pharmacology and Therapeutics·C WiuffO Svendsen
Jul 3, 2013·Avian Pathology : Journal of the W.V.P.A·Joan A St AmandColleen B Annett Christianson
Nov 29, 2007·Foodborne Pathogens and Disease·Anna Catharina B BergeWilliam M Sischo
Jul 23, 2009·Foodborne Pathogens and Disease·Nantika Soonthornchaikul, Hemda Garelick
Mar 14, 2007·Antimicrobial Agents and Chemotherapy·Jun LinQijing Zhang
May 29, 2008·Antimicrobial Agents and Chemotherapy·Byeonghwa JeonQijing Zhang
May 4, 2005·Environmental Health Perspectives·Lance B PriceEllen Silbergeld
Mar 5, 2009·Future Microbiology·Taradon LuangtongkumQijing Zhang
Aug 22, 2003·Journal of the American Veterinary Medical Association·Sean F Altekruse, Linda K Tollefson
Jun 23, 2004·Emerging Infectious Diseases·Amita GuptaUNKNOWN NARMS Working Group
Aug 31, 2012·Emerging Infectious Diseases·Allen C ChengThomas Gottlieb
Jun 15, 2013·Emerging Infectious Diseases·Agnes AgunosLucie Dutil
Jan 25, 2013·International Journal of Environmental Research and Public Health·Paulo Martins da CostaAugusto J F Matos
Jul 19, 2013·BioMed Research International·Kinga Wieczorek, Jacek Osek
Oct 12, 2007·Future Microbiology·Jeffrey M GilbertPatrick F McDermott
Jan 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Naidan LuoQijing Zhang
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Herbert L DuPont
Apr 5, 2013·BioMed Research International·Diana StoneRavindra Sharma
Feb 2, 2010·Veterinary Microbiology·Xia ChenJian-Zhong Shen
Mar 1, 2008·International Journal of Antimicrobial Agents·Anna FàbregaJordi Vila
Mar 25, 2005·Risk Analysis : an Official Publication of the Society for Risk Analysis·Mary J BartholomewCurtis C Travis
Sep 29, 2009·Microbiology and Immunology·Sunyoung HwangSangryeol Ryu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Campylobacteriosis

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.